Felbamate-d4

• CAT Number: R008971
• CAS Number: 106817-52-1
• Molecular Formula: C11H14N2O4
• Molecular Weight: 242.267
• Purity: ≥95%
• Synonyms: 2-Phenyl-1,3-propanedioldicarbamate-d4; Carbamic Acid 2-Phenyltrimethylene-d4 Ester; ADD-03055-d4; W-554-d4; Felbamyl-d4; Felbatol-d4; Taloxa-d4
• Target: Neuronal Signaling
• Storage: Store at -20°C
• IUPAC Name: (3-carbamoyloxy-1,1,3,3-tetradeuterio-2-phenylpropyl) carbamate
• InChI: InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)/i6D2,7D2
• InChIKey: WKGXYQFOCVYPAC-KXGHAPEVSA-N
• SMILES: [2H]C([2H])(C(C1=CC=CC=C1)C([2H])([2H])OC(=O)N)OC(=O)N

Felbamate-d4 is a deuterated form of felbamate, an antiepileptic drug used to treat seizures. The incorporation of four deuterium atoms enhances its utility in studying the drug’s pharmacokinetics and metabolism. The deuterium labeling allows researchers to precisely track felbamate’s absorption, distribution, metabolism, and excretion in the body. This detailed information aids in understanding the drug’s behavior, optimizing dosing regimens, and evaluating its efficacy and safety. The insights gained from such studies contribute to improving therapeutic strategies and drug development for epilepsy treatment.